| 421/1816 | US=16 / Estatística Kumar D, Verma M. Methods in cancer epigenetics and epidemiology. In: Verma M. Cancer epidemiology. New York: Humana Press, 2009. p. 273-88. (Methods in Molecular Biology, 471) ISBN 978-1-58829-987-1. CANCER. EPIDEMIOLOGIA; EPIGENETICA; ACETILACAO; BIOMARCADOR; CROMATINA; EPIGENETICA; HISTONA; HISTONA DESACETILASE (HDAC); HISTONA ACETILTRANSFERASE (HAT); METILACAO; METILTRANSFERASE; AVALIACAO DE RISCO; TRIAGEM |
| 422/1816 | US=16 / Estatística Singh KK, Kulawiec M. Mitochondrial DNA polymorphism and risk of cancer. In: Verma M. Cancer epidemiology. New York: Humana Press, 2009. p. 291-303. (Methods in Molecular Biology, 471) ISBN 978-1-58829-987-1. POLIMORFISMO DE DNA MITOCONDRIAL; RISCO DE CANCER; APOPTOSE; MITOCONDRIA; FOSFORILACAO OXIDATIVA; POLIMORFISMO; ESPECIES REATIVAS DE OXIGENIO |
| 423/1816 | US=16 / Estatística Jiang J, Zhang X, Yang H, Wang W. Polymorphisms of DNA repair genes: ADPRT, XRCC1, and XPD and cancer risk in genetic epidemiology. In: Verma M. Cancer epidemiology. New York: Humana Press, 2009. p. 305-33. (Methods in Molecular Biology, 471) ISBN 978-1-58829-987-1. POLIMORFISMOS; GENES DE REPARO DO DNA; ADPRT; XRCC1; XPD; RISCO DE CANCER; EPIDEMIOLOGIA GENETICA |
| 424/1816 | US=16 / Estatística Xu XC. Risk factors and gene expression in esophageal cancer. In: Verma M. Cancer epidemiology. New York: Humana Press, 2009. p. 335-60. (Methods in Molecular Biology, 471) ISBN 978-1-58829-987-1. CANCER DE ESOFAGO; FATORES DE RISCO; EXPRESSAO GENICA; TABAGISMO; ALCOOLISMO; REFLUXO GASTROESOFAGICO; ALTERACOES GENETICAS; CANCER. PREVENCAO; ESOFAGO DE BARRET; ADENOCARCINOMA ESOFAGICO; MUTACAO DO GENE P53; ALTERACAO DO GENE P16; RECEPTOR DO FATOR DE CRESCIMENTO EPIDERMAL (EGFR); CADERINA-E; COX-2; QUIMIOPREVENCAO; ACIDOS RETINOICOS; ANTI-INFLAMATORIOS NAO ESTEROIDES; EGCG; CURCUMINA |
| 425/1816 | US=16 / Estatística Park JY, Huang Y, Sellers TA. Single nucleotide polymorphisms in DNA repair genes and prostate cancer risk. In: Verma M. Cancer epidemiology. New York: Humana Press, 2009. p. 361-85. (Methods in Molecular Biology, 471) ISBN 978-1-58829-987-1. REPARO DE DNA; POLIMORFISMO; EXPOSICAO AMBIENTAL; CANCER DE PROSTATA; SUSCETIBILIDADE AO CANCER |
| 426/1816 | US=16 / Estatística Kalt I, Masa SR, Sarid R. Linking the Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) to human malignancies. In: Verma M. Cancer epidemiology. New York: Humana Press, 2009. p. 387-407. (Methods in Molecular Biology, 471) ISBN 978-1-58829-987-1. HERPESVIRUS ASSOCIADO AO SARCOMA DE KAPOSI (KSHV); HERPESVIRUS HUMANO TIPO 8 (HHV-8); SARCOMA DE KAPOSI; LINFOMA PRIMARIO; DOENCA DE CASTLEMAN |
| 427/1816 | US=16 / Estatística Serraino D, Piselli P. Cancer cohort consortium approach: cancer epidemiology in immunosuppressed groups. In: Verma M. Cancer epidemiology. New York: Humana Press, 2009. p. 409-19. (Methods in Molecular Biology, 471) ISBN 978-1-58829-987-1. CANCER. FATORES DE RISCO; HIV; IMUNOSSUPRESSAO; RECEPTORES DE TRANSPLANTES; SUL DA EUROPA |
| 428/1816 | US=16 / Estatística Lawson JS. Do viruses cause breast cancer?. In: Verma M. Cancer epidemiology. New York: Humana Press, 2009. p. 421-38. (Methods in Molecular Biology, 471) ISBN 978-1-58829-987-1. CANCER DE MAMA; VIRUS; VIRUS DE TUMOR MAMARIO DOS RATOS (MMTV); VIRUS DO PAPILOMA HUMANO; HPV; DIETA; ALIMENTO; HORMONIO |
| 429/1816 | US=16 / Estatística Chauhan SC, Jaggi M, Bell MC, Verma M, Kumar D. Epidemiology of human papilloma virus (HPV) in cervical mucosa. In: Verma M. Cancer epidemiology. New York: Humana Press, 2009. p. 439-56. (Methods in Molecular Biology, 471) ISBN 978-1-58829-987-1. PAPILOMAVIRUS HUMANO; HPV; EPIGENETICA; EPIDEMIOLOGIA; CANCER CERVICAL |
| 430/1816 | US=16 / Estatística Dumitrescu RG. Epigenetic targets in cancer epidemiology. In: Verma M. Cancer epidemiology. New York: Humana Press, 2009. p. 457-67. (Methods in Molecular Biology, 471) ISBN 978-1-58829-987-1. CANCER. EPIDEMIOLOGIA; EPIGENETICA; HIPERMETILACAO; HIPOMETILACAO; DNA; CROMATINA; DESENVOLVIMENTO DO CANCER; SUSCETIBILIDADE AO CANCER; CANCER DE BEXIGA; CANCER NO CEREBRO; CANCER DE MAMA; CANCER CERVICAL; CANCER COLORRETAL; CANCER DE PULMAO; CANCER DE PROSTATA; CANCER DE OVARIO |
| 431/1816 | US=16 / Estatística Yang P. Epidemiology of lung cancer prognosis: quantity and quality of life. In: Verma M. Cancer epidemiology. New York: Humana Press, 2009. p. 469-86. (Methods in Molecular Biology, 471) ISBN 978-1-58829-987-1. CANCER DE PULMAO DE CELULAS NAO-PEQUENAS; CANCER DE PULMAO DE PEQUENAS CELULAS; SOBREVIVENCIA; QUALIDADE DE VIDA; FARMACOGENOMICA; PERFIL DE EXPRESSAO GENICA; QUIMIOTERAPIA; RADIOTERAPIA; TOXICIDADE |
| 432/1816 | US=16 / Estatística Simon MS, Petrucelli N. Hereditary breast and ovarian cancer syndrome: the impact of race on uptak of genetic counseling and testing. In: Verma M. Cancer epidemiology. New York: Humana Press, 2009. p. 487-500. (Methods in Molecular Biology, 471) ISBN 978-1-58829-987-1. CANCER DE MAMA; BRCA1; BRCA2; CUIDADOS PRIMARIOS; CANCER DE OVARIO |
| 433/1816 | US=19 / Biol/Mol Hager S, Maitland NJ, Collins A. Prostate cancer stem cells. In: Bapat S. Cancer stem cells: identification and targets. New Jersey: John Wiley & Sons, 2009. p. 111-34. ISBN 978-0-470-12201-3. CELULAS-TRONCO; CANCER DE PROSTATA; PROSTATA HUMANA; CELULAS EPITELIAIS DA PROSTATA |
| 434/1816 | US=9 / Quimioterapia Nersesyan A, Misík M, Knasmüller S. Methods used for the detection of antimutagens: an overview. In: Knasmüller S, DeMarini DM, Johnson I, Gerhäuser C. Chemoprevention of cancer and DNA damage by dietary factors. Weinheim: Wiley-VCH, 2009. p. 211-27. ISBN 978-3-527-32058-5. DETECCAO DE ANTIMUTAGENOS; MECANISMOS DE PROTECAO DO DNA; ANTIGENOTOXICIDADE; SISTEMA IN VITRO; BIOMONITORIZACAO HUMANA |
| 435/1816 | US=22 / Urologia Bukowski RM, Figlin RA, Motzer RJ. Targeted therapy for metastatic renal cell carcinoma: overview. In: ___. Renal cell carcinoma: molecular targets and clinical applications. 2ªed. New York: Humana Press, 2009. p. 1-12. ISBN 978-1-58829-737-2. CARCINOMA DE CELULAS RENAIS; VHL GENE; PROTEINA VHL; VEGF; PDGF; TERAPIAS RCC |
| 436/1816 | US=22 / Urologia Dhanani N, Vocke C, Bratslavsky G, Linehan WM. Molecular genetics in inherited renal cell carcinoma: identification of targets in the hereditary syndromes. In: Bukowski RM, Figlin RA, Motzer RJ. Renal cell carcinoma: molecular targets and clinical applications. 2ªed. New York: Humana Press, 2009. p. 13-33. ISBN 978-1-58829-737-2. NEOPLASIAS DE RIM; HIPPLE CON-LINDAU; BHD; BIRT-HOGG-DUBE; FUMARATO HIDRATASE |
| 437/1816 | US=22 / Urologia Zhou M. Molecular targets in renal tumors: pathologic assessment. In: Bukowski RM, Figlin RA, Motzer RJ. Renal cell carcinoma: molecular targets and clinical applications. 2ªed. New York: Humana Press, 2009. p. 35-48. ISBN 978-1-58829-737-2. CARCINOMA DE CELULAS RENAIS; NEOPLASIA RENAL PATOLOGIA; CITOGENETICA; PROGNOSTICO |
| 438/1816 | US=22 / Urologia Hutson TE, Thakkar S, Cohen P, Borden EC. Interferons and interleukin-2: molecular basis of activity and therapeutic results. In: Bukowski RM, Figlin RA, Motzer RJ. Renal cell carcinoma: molecular targets and clinical applications. 2ªed. New York: Humana Press, 2009. p. 49-78. ISBN 978-1-58829-737-2. INTERFERON; INTERLEUCINA; IFN-X2, IL-2; INIBICAO DA ANGIOGENESE; EFEITOS CLINICOS DA IL-2 E IFN |
| 439/1816 | US=22 / Urologia Junior Kaelin WG, Geoge DJ. The molecular biology of kidney cancer and its clinical translation into treatment strategies. In: Bukowski RM, Figlin RA, Motzer RJ. Renal cell carcinoma: molecular targets and clinical applications. 2ªed. New York: Humana Press, 2009. p. 79-97. ISBN 978-1-58829-737-2. VON HIPPEL-LINDAU; HIPOXIA; ANGIOGENESE; HIF; VEGF; KDR; MTOR |
| 440/1816 | US=22 / Urologia Rathmell WK, Rini BI. VEGF: biologic aspects and clinical approaches. In: Bukowski RM, Figlin RA, Motzer RJ. Renal cell carcinoma: molecular targets and clinical applications. 2ªed. New York: Humana Press, 2009. p. 99-118. ISBN 978-1-58829-737-2. |